FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.

A review of EMR data from younger and older women with breast cancer noted that social support was not consistently documented among patients.

Researchers sought to determine whether adding fixed-duration venetoclax to RBAC in the first line would be effective in older patients with high-risk MCL.

In order to understand how patients are affected by receiving notification of their breast density, Australian researchers conducted a randomized, multi-arm trial of 2401 women with dense breasts.

In this retrospective cohort study, researchers aimed to characterize the risk factors associated with late-onset depression in long-term cancer survivors.

In this retrospective cohort study, researchers investigated the association between travel time and mortality in prostate cancer patients.

In this study, researchers sought to determine whether Medicaid expansion led to improvements in survival for patients with resectable NSCLC.

In this study, researchers explored disparities in metastatic cutaneous melanoma survival following the introduction of immunotherapies.

Fourfold increased occurrence of bladder cancer seen in those with T1D after adjustment for smoking as a confounder ...

Researchers sought to determine whether adding mogamulizumab to CHOP would improve outcomes in older patients with adult T-cell leukemia/lymphoma.